TSX-V:MRVL - TSX Venture Exchange - CA57384M1077 - Common Stock - Currency: CAD
TSX-V:MRVL (5/5/2025, 7:00:00 PM)
0.085
0 (0%)
The current stock price of MRVL.CA is 0.085 CAD. In the past month the price decreased by -32%. In the past year, price decreased by -37.04%.
Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-02-28. The firm develops new synthetic chemical derivatives of the original approved drug for the new disease indication. The company has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The firm's lead compound, MB-204, is a fluorinated derivative of Istradefylline. The firm is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.
MARVEL BIOSCIENCES CORP
Suite 420, 505 8th Avenue S.W.
Calgary ALBERTA CA
Employees: 0
Phone: 14037702469
The current stock price of MRVL.CA is 0.085 CAD.
The exchange symbol of MARVEL BIOSCIENCES CORP is MRVL and it is listed on the TSX Venture Exchange exchange.
MRVL.CA stock is listed on the TSX Venture Exchange exchange.
MARVEL BIOSCIENCES CORP (MRVL.CA) has a market capitalization of 3.81M CAD. This makes MRVL.CA a Nano Cap stock.
MARVEL BIOSCIENCES CORP (MRVL.CA) currently has 0 employees.
MARVEL BIOSCIENCES CORP (MRVL.CA) has a resistance level at 0.1. Check the full technical report for a detailed analysis of MRVL.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MRVL.CA does not pay a dividend.
MARVEL BIOSCIENCES CORP (MRVL.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
Over the last trailing twelve months MRVL.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 45.57% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -616.57% | ||
ROE | N/A | ||
Debt/Equity | N/A |